Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Postnatal intervention for the treatment of FNAIT: a systematic review.

Baker JM, Shehata N, Bussel J, Murphy MF, Greinacher A, Bakchoul T, Massey E, Lieberman L, Landry D, Tanael S, Arnold DM, Baidya S, Bertrand G, Kjaer M, Kaplan C, Kjeldsen-Kragh J, Oepkes D, Savoia H, Ryan G, Hume H; International Collaboration for Transfusion Medicine Guidelines (ICTMG).

J Perinatol. 2019 Oct;39(10):1329-1339. doi: 10.1038/s41372-019-0360-7. Epub 2019 Apr 10. Review.

PMID:
30971767
2.

HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women.

Kjeldsen-Kragh J, Titze TL, Lie BA, Vaage JT, Kjær M.

Blood Adv. 2019 Apr 9;3(7):945-951. doi: 10.1182/bloodadvances.2019032227.

3.

Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach.

Lieberman L, Greinacher A, Murphy MF, Bussel J, Bakchoul T, Corke S, Kjaer M, Kjeldsen-Kragh J, Bertrand G, Oepkes D, Baker JM, Hume H, Massey E, Kaplan C, Arnold DM, Baidya S, Ryan G, Savoia H, Landry D, Shehata N; International Collaboration for Transfusion Medicine Guidelines (ICTMG).

Br J Haematol. 2019 May;185(3):549-562. doi: 10.1111/bjh.15813. Epub 2019 Mar 3.

PMID:
30828796
4.

Risk of HPA-1a-immunization in HPA-1a-negative women after giving birth to an HPA-1a-positive child.

Kjeldsen-Kragh J, Olsen KJ.

Transfusion. 2019 Apr;59(4):1344-1352. doi: 10.1111/trf.15152. Epub 2019 Feb 6.

PMID:
30729532
5.

Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.

Kjaer M, Bertrand G, Bakchoul T, Massey E, Baker JM, Lieberman L, Tanael S, Greinacher A, Murphy MF, Arnold DM, Baidya S, Bussel J, Hume H, Kaplan C, Oepkes D, Ryan G, Savoia H, Shehata N, Kjeldsen-Kragh J; International Collaboration for Transfusion Medicine Guidelines.

Vox Sang. 2019 Jan;114(1):79-94. doi: 10.1111/vox.12725. Epub 2018 Nov 22.

PMID:
30565711
6.

New elegant methods for maternal and fetal HPA-1a typing.

Kjeldsen-Kragh J.

Transfusion. 2018 Oct;58(10):2253-2254. doi: 10.1111/trf.14954. Epub 2018 Sep 21. No abstract available.

PMID:
30238992
7.

Determination of fetal RHD type in plasma of RhD negative pregnant women.

Sørensen K, Kjeldsen-Kragh J, Husby H, Akkök ÇA.

Scand J Clin Lab Invest. 2018 Sep;78(5):411-416. doi: 10.1080/00365513.2018.1475681. Epub 2018 Jun 5.

PMID:
29869532
8.

Screening for fetal and neonatal alloimmune thrombocytopenia - lessons learned from a Norwegian screening program.

Kjaer M, Kjeldsen-Kragh J, Fiskum C, Leinan I, Skogen B, Husebekk A.

Acta Obstet Gynecol Scand. 2018 Jun;97(6):766-767. doi: 10.1111/aogs.13320. Epub 2018 Mar 5. No abstract available.

PMID:
29412452
9.

Linear decline of corrected platelet count increment within 24 hours after platelet transfusion in haematological patients: A prospective observational study.

Benediktsson S, Lazarevic V, Nilsson L, Kjeldsen-Kragh J, Schött U, Kander T.

Eur J Haematol. 2017 Dec;99(6):559-568. doi: 10.1111/ejh.12974. Epub 2017 Oct 16.

PMID:
28952164
10.

Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study.

Kjær M, Tiller H, Heide G, Kjeldsen-Kragh J, Skogen B, Husebekk A.

PLoS One. 2017 Aug 24;12(8):e0182957. doi: 10.1371/journal.pone.0182957. eCollection 2017.

11.

Prevention of alloimmunization during pregnancy by prednisone and immunoglobulin G-What is the evidence?

Kjeldsen-Kragh J.

Am J Reprod Immunol. 2017 Sep;78(3). doi: 10.1111/aji.12697. Epub 2017 May 30. No abstract available.

PMID:
28557047
12.

Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review.

Winkelhorst D, Murphy MF, Greinacher A, Shehata N, Bakchoul T, Massey E, Baker J, Lieberman L, Tanael S, Hume H, Arnold DM, Baidya S, Bertrand G, Bussel J, Kjaer M, Kaplan C, Kjeldsen-Kragh J, Oepkes D, Ryan G.

Blood. 2017 Mar 16;129(11):1538-1547. doi: 10.1182/blood-2016-10-739656. Epub 2017 Jan 27. Review.

PMID:
28130210
13.

Sensitive detection of platelet-specific antibodies with a modified MAIPA using biotinylated antibodies and streptavidin-coated beads.

Mörtberg A, Meinke S, Berg P, Killie MK, Kjeldsen-Kragh J, Järås K, Refsum E, Höglund P, Wikman A.

J Immunol Methods. 2016 Jul;434:9-15. doi: 10.1016/j.jim.2016.04.001. Epub 2016 Apr 5.

PMID:
27059653
14.

Fetal and neonatal alloimmune thrombocytopenia.

Zdravic D, Yougbare I, Vadasz B, Li C, Marshall AH, Chen P, Kjeldsen-Kragh J, Ni H.

Semin Fetal Neonatal Med. 2016 Feb;21(1):19-27. doi: 10.1016/j.siny.2015.12.004. Epub 2016 Jan 20. Review.

PMID:
26810319
15.

Acoustophoretic removal of proteins from blood components.

Tenje M, Lundgren MN, Swärd-Nilsson AM, Kjeldsen-Kragh J, Lyxe L, Lenshof A.

Biomed Microdevices. 2015 Oct;17(5):95. doi: 10.1007/s10544-015-0003-5.

PMID:
26315975
16.

Paroxysmal nocturnal haemoglobinuria at Oslo University Hospital 2000-2010.

Nissen-Meyer LS, Tjønnfjord GE, Golebiowska E, Kjeldsen-Kragh J, Akkök ÇA.

Tidsskr Nor Laegeforen. 2015 Jun 16;135(11):1039-43. doi: 10.4045/tidsskr.14.0444. eCollection 2015 Jun 16. English, Norwegian.

17.

True risk of fetal/neonatal alloimmune thrombocytopenia in subsequent pregnancies: a prospective observational follow-up study.

Tiller H, Husebekk A, Skogen B, Kjeldsen-Kragh J, Kjaer M.

BJOG. 2016 Apr;123(5):738-44. doi: 10.1111/1471-0528.13343. Epub 2015 Mar 9.

18.

Bacterial contamination in platelet concentrates.

Pietersz RN, Reesink HW, Panzer S, Oknaian S, Kuperman S, Gabriel C, Rapaille A, Lambermont M, Deneys V, Sondag D, Ramírez-Arcos S, Goldman M, Delage G, Bernier F, Germain M, Vuk T, Georgsen J, Morel P, Naegelen C, Bardiaux L, Cazenave JP, Dreier J, Vollmer T, Knabbe C, Seifried E, Hourfar K, Lin CK, Spreafico M, Raffaele L, Berzuini A, Prati D, Satake M, de Korte D, van der Meer PF, Kerkhoffs JL, Blanco L, Kjeldsen-Kragh J, Svard-Nilsson AM, McDonald CP, Symonds I, Moule R, Brailsford S, Yomtovian R, Jacobs MR.

Vox Sang. 2014 Apr;106(3):256-83. doi: 10.1111/vox.12098. Review. No abstract available.

PMID:
24654780
19.

Mechanisms and prevention of alloimmunization in pregnancy.

Kjeldsen-Kragh J, Skogen B.

Obstet Gynecol Surv. 2013 Jul;68(7):526-32. doi: 10.1097/OGX.0b013e3182947ce4. Review.

PMID:
23803755
20.

3',4'-Dimethoxyflavone and valproic acid promotes the proliferation of human hematopoietic stem cells.

Kaur K, Mirlashari MR, Kvalheim G, Kjeldsen-Kragh J.

Stem Cell Res Ther. 2013 May 24;4(3):60. doi: 10.1186/scrt208.

21.

Bleeding complications after central line insertions: relevance of pre-procedure coagulation tests and institutional transfusion policy.

Kander T, Frigyesi A, Kjeldsen-Kragh J, Karlsson H, Rolander F, Schött U.

Acta Anaesthesiol Scand. 2013 May;57(5):573-9. doi: 10.1111/aas.12075. Epub 2013 Jan 21.

PMID:
23336361
22.

Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia.

Kjeldsen-Kragh J, Ni H, Skogen B.

Curr Opin Hematol. 2012 Nov;19(6):469-74. doi: 10.1097/MOH.0b013e328358f86c. Review.

PMID:
22954726
23.

Biological response modifiers in photochemically pathogen-reduced versus untreated apheresis platelet concentrates.

Vetlesen A, Mirlashari MR, Akkök CA, Kelher MR, Khan SY, Silliman CC, Kjeldsen-Kragh J.

Transfusion. 2013 Jan;53(1):147-55. doi: 10.1111/j.1537-2995.2012.03681.x. Epub 2012 May 7.

24.

Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.

Tiller H, Killie MK, Chen P, Eksteen M, Husebekk A, Skogen B, Kjeldsen-Kragh J, Ni H.

Transfusion. 2012 Jul;52(7):1446-57. doi: 10.1111/j.1537-2995.2011.03480.x. Epub 2012 Jan 17.

PMID:
22251227
25.

Glycogen synthase kinase-3 (GSK-3) inhibition induces apoptosis in leukemic cells through mitochondria-dependent pathway.

Mirlashari MR, Randen I, Kjeldsen-Kragh J.

Leuk Res. 2012 Apr;36(4):499-508. doi: 10.1016/j.leukres.2011.11.013. Epub 2011 Dec 15.

PMID:
22177455
26.

The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes.

Ahlen MT, Husebekk A, Killie MK, Kjeldsen-Kragh J, Olsson ML, Skogen B.

Clin Dev Immunol. 2012;2012:156867. doi: 10.1155/2012/156867. Epub 2011 Nov 2.

27.

Recovery, survival, and function of transfused platelets and detection of platelet engraftment after allogeneic stem cell transplantation.

Vetlesen A, Holme PA, Lyberg T, Kjeldsen-Kragh J.

Transfusion. 2012 Jun;52(6):1321-32. doi: 10.1111/j.1537-2995.2011.03442.x. Epub 2011 Nov 16.

PMID:
22084943
28.

Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys.

Tiller H, Killie MK, Husebekk A, Skogen B, Ni H, Kjeldsen-Kragh J, Øian P.

Acta Obstet Gynecol Scand. 2012 Jan;91(1):79-86. doi: 10.1111/j.1600-0412.2011.01269.x. Epub 2011 Oct 13.

PMID:
21895612
29.

The pathophysiology of FNAIT cannot be deduced from highly selected retrospective data.

Kjeldsen-Kragh J, Husebekk A, Killie MK, Skogen B.

Blood. 2011 Sep 1;118(9):2638-9. doi: 10.1182/blood-2011-06-360404. No abstract available.

PMID:
21885616
30.

[Fetal and neonatal alloimmune thrombocytopenia].

Taaning EB, Kjeldsen-Kragh J, Hedegaard M, Hegaard HK, Henriksen TB, Hvas AM, Kjærgaard H, Rasmussen OB.

Ugeskr Laeger. 2011 Aug 22;173(34):2041-4. Danish.

PMID:
21867657
31.

Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention.

Skogen B, Killie MK, Kjeldsen-Kragh J, Ahlen MT, Tiller H, Stuge TB, Husebekk A.

Expert Rev Hematol. 2010 Oct;3(5):559-66. doi: 10.1586/ehm.10.49. Review.

PMID:
21083473
32.

Neonatal alloimmune thrombocytopenia is not what it was: a lesson learned from a large prospective screening and intervention program.

Skogen B, Husebekk A, Killie MK, Kjeldsen-Kragh J.

Scand J Immunol. 2009 Dec;70(6):531-4. doi: 10.1111/j.1365-3083.2009.02339.x. Review.

33.

Is it time to implement HPA-1 screening in pregnancy?

Husebekk A, Killie MK, Kjeldsen-Kragh J, Skogen B.

Curr Opin Hematol. 2009 Nov;16(6):497-502. doi: 10.1097/MOH.0b013e3283317be9. Review.

PMID:
19730261
34.

In HPA 1a-immunized women the decrease in anti-HPA 1a antibody level during pregnancy is not associated with anti-idiotypic antibodies.

Kjeldsen-Kragh J, Kim M, Killie MK, Husebekk A, Freedman J, Semple JW.

Haematologica. 2009 Mar;94(3):441-3. doi: 10.3324/haematol.13827. Epub 2009 Jan 30. No abstract available.

35.

Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme?

Kjeldsen-Kragh J, Husebekk A, Killie MK, Skogen B.

Transfus Apher Sci. 2008 Jun;38(3):183-8. doi: 10.1016/j.transci.2008.04.010. Epub 2008 May 21. Review.

PMID:
18499524
36.

A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn.

Killie MK, Husebekk A, Kjeldsen-Kragh J, Skogen B.

Haematologica. 2008 Jun;93(6):870-7. doi: 10.3324/haematol.12515. Epub 2008 Apr 28.

37.

Accurate Rh phenotype determination by reticulocyte mRNA typing shortly after multiple transfusions.

Randen I, Sørensen K, Hauge R, Dahlberg AB, Mirlashari MR, Thompson KM, Kjeldsen-Kragh J.

Haematologica. 2008 Apr;93(4):627-30. doi: 10.3324/haematol.11356. Epub 2008 Mar 6.

38.

Management of alloimmune thrombocytopenia.

Kanhai HH, Porcelijn L, Engelfriet CP, Reesink HW, Panzer S, Ulm B, Goldman M, Bonacossa I, Richard L, David M, Taaning E, Hedegaard M, Kaplan C, Kiefel V, Meyer O, Salama A, Morelati F, Greppi N, Marconi M, Tassis B, Tsuno NH, Takahashi K, Oepkes D, Porcelijn L, Kanhai H, Osnes LT, Husebekk A, Killie MK, Kjeldsen-Kragh J, Zupanska B, Muñiz-Diaz E, Nogués N, Parra J, Urbaniak SJ, Cameron A.

Vox Sang. 2007 Nov;93(4):370-85. No abstract available.

PMID:
18070283
39.

Detection of bacterial contamination of platelet concentrates.

Pietersz RN, Engelfriet CP, Reesink HW, Wood EM, Winzar S, Keller AJ, Wilson JT, Henn G, Mayr WR, Ramirez-Arcos S, Goldman M, Georgsen J, Morel P, Herve P, Andeu G, Assal A, Seifried E, Schmidt M, Foley M, Doherty C, Coakley P, Salami A, Cadden E, Murphy WG, Satake M, de Korte D, Bosnes V, Kjeldsen-Kragh J, McDonald C, Brecher ME, Yomtovian R, AuBuchon JP.

Vox Sang. 2007 Oct;93(3):260-77. No abstract available.

PMID:
17845264
40.

Evaluation of nonleukoreduced red blood cell transfusion units collected at delivery from the placenta.

Widing L, Bechensteen AG, Mirlashari MR, Vetlesen A, Kjeldsen-Kragh J.

Transfusion. 2007 Aug;47(8):1481-7.

PMID:
17655592
41.

Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.

Akkök CA, Brinch L, Lauritzsen GF, Solheim BG, Kjeldsen-Kragh J.

Vox Sang. 2007 Jul;93(1):42-8.

PMID:
17547564
42.

A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia.

Kjeldsen-Kragh J, Killie MK, Tomter G, Golebiowska E, Randen I, Hauge R, Aune B, Øian P, Dahl LB, Pirhonen J, Lindeman R, Husby H, Haugen G, Grønn M, Skogen B, Husebekk A.

Blood. 2007 Aug 1;110(3):833-9. Epub 2007 Apr 11.

PMID:
17429009
43.

Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia.

Killie MK, Kjeldsen-Kragh J, Husebekk A, Skogen B, Olsen JA, Kristiansen IS.

BJOG. 2007 May;114(5):588-95. Epub 2007 Mar 13. Erratum in: BJOG. 2007 Nov;114(11):1453.

44.

Effect of limbal explant orientation on the histology, phenotype, ultrastructure and barrier function of cultured limbal epithelial cells.

Raeder S, Utheim TP, Utheim OA, Cai Y, Roald B, Lyberg T, Kjeldsen-Kragh J, Ramstad H, Messelt E, Nicolaissen B Jr.

Acta Ophthalmol Scand. 2007 Jun;85(4):377-86. Epub 2007 Jan 31.

45.
46.

The effect of pre-storage cooling on 2,3-DPG levels in red cells stored in SAG-M.

Llohn AH, Vetlesen A, Fagerhol MK, Kjeldsen-Kragh J.

Transfus Apher Sci. 2005 Oct;33(2):113-8.

PMID:
16109505
47.
49.

Positive BacT/ALERT signal from a platelet concentrate 23 h before the donor was admitted to hospital with Streptococcus pneumoniae septicaemia.

Larsen CP, Hermansen NO, Dahl T, Kjeldsen-Kragh J.

Vox Sang. 2004 Nov;87(4):299-301. No abstract available.

PMID:
15585027
50.

The platelet count accuracy of platelet concentrates obtained by using automated analysis is influenced by instrument bias and activated platelet components.

Hervig T, Haugen T, Liseth K, Kjeldsen-Kragh J, Scott CS, Johannessen B.

Vox Sang. 2004 Oct;87(3):196-203.

PMID:
15569073

Supplemental Content

Loading ...
Support Center